Trial Profile
A phase 3 study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) With tacalcitol ointment (4 mcg/g) and gel vehicle, used once daily in the treatment of psoriasis vulgaris.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2015
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Tacalcitol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 05 Mar 2010 Secondary endpoint 'Psoriasis Area and Severity Index' has been met according to results presented at the 68th Annual Meeting of the American Academy of Dermatology.
- 05 Mar 2010 Primary endpoint 'Disease control rate' has been met according to results presented at the 68th Annual Meeting of the American Academy of Dermatology.
- 05 Mar 2010 Results presented at the 68th Annual Meeting of the American Academy of Dermatology.